Aclaris Therapeutics, Inc.
ACRS
$4.88
-$0.07-1.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.10% | -20.11% | -24.91% | -10.16% | -17.83% |
| Total Receivables | 1,825.60% | -54.96% | 1,264.43% | -40.31% | -32.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -32.41% | -52.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.32% | -23.53% | -23.98% | -11.42% | -19.62% |
|
|
|||||
| Total Current Assets | 1.32% | -23.53% | -23.98% | -11.42% | -19.62% |
| Net Property, Plant & Equipment | -20.88% | -20.88% | -21.13% | -21.82% | -30.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -47.97% | 116.96% | 67.08% | 61.83% | 58.01% |
| Total Assets | 0.32% | -27.17% | -3.76% | 17.43% | 13.80% |
|
|
|||||
| Total Accounts Payable | 131.84% | 180.55% | 19.90% | 21.02% | -41.22% |
| Total Accrued Expenses | -0.96% | -4.47% | 85.84% | 42.46% | 43.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.26% | 14.55% | 14.62% | 14.70% | -0.99% |
| Total Finance Division Other Current Liabilities | -25.27% | -59.70% | 33.50% | 177.99% | 80.59% |
| Total Other Current Liabilities | -25.27% | -59.70% | 33.50% | 177.99% | 80.59% |
| Total Current Liabilities | 27.22% | -9.34% | 36.22% | 71.15% | 7.14% |
|
|
|||||
| Total Current Liabilities | 27.22% | -9.34% | 36.22% | 71.15% | 7.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -28.70% | -26.07% | -23.79% | -21.80% | -33.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.90% | -12.53% | -9.91% | 212.15% | 239.20% |
| Total Liabilities | 1.93% | -11.42% | 6.11% | 110.68% | 68.57% |
|
|
|||||
| Common Stock & APIC | 6.56% | 1.13% | 14.04% | 14.11% | 14.13% |
| Retained Earnings | -7.59% | -7.19% | -17.57% | -16.86% | -16.53% |
| Treasury Stock & Other | -94.93% | 528.87% | 39.81% | 204.10% | 219.23% |
| Total Common Equity | -0.29% | -33.73% | -7.72% | -1.56% | 1.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.29% | -33.73% | -7.72% | -1.56% | 1.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.29% | -33.73% | -7.72% | -1.56% | 1.44% |
|
|
|||||